C

China National Accord Medicines Corp Ltd
SZSE:000028

Watchlist Manager
China National Accord Medicines Corp Ltd
SZSE:000028
Watchlist
Price: 26.21 CNY -2.57% Market Closed
Market Cap: 12.7B CNY
Have any thoughts about
China National Accord Medicines Corp Ltd?
Write Note

China National Accord Medicines Corp Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China National Accord Medicines Corp Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Accord Medicines Corp Ltd
SZSE:000028
Revenue
ÂĄ75.4B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
12%
Sinopharm Group Co Ltd
HKEX:1099
Revenue
ÂĄ590.3B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
13%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Revenue
ÂĄ272.4B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
12%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Revenue
ÂĄ149.2B
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
14%
C
China National Medicines Corp Ltd
SSE:600511
Revenue
ÂĄ51.2B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
16%
Huadong Medicine Co Ltd
SZSE:000963
Revenue
ÂĄ41.7B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
9%
No Stocks Found

China National Accord Medicines Corp Ltd
Glance View

Market Cap
12.7B CNY
Industry
Health Care

China National Accord Medicines Corp Ltd, nestled within the bustling healthcare landscape of China, operates at the heart of the pharmaceutical distribution and retail sectors. Established with the goal of ensuring that essential medicines and healthcare services are accessible to the vast Chinese population, the company has built an extensive distribution network. This network efficiently links manufacturers with hospitals, clinics, and pharmacies, making certain that a myriad of pharmaceutical products reach their intended destinations. By leveraging a combination of logistical prowess and vast geographical coverage, the company adeptly navigates the complexities of supply chain management, underscoring its role as a critical player in China's healthcare infrastructure. Beyond distribution, China National Accord Medicines also capitalizes on the booming retail pharmaceuticals market through its chain of pharmacies. These retail outlets serve as direct points of sale to consumers, offering both prescription and over-the-counter medications, alongside health consultation services. This dual focus on both wholesale distribution and retail outlets enables the company to capture value across the supply chain, from manufacturer to end-user. The strategic alignment of its operations streamlines efficiency and generates revenue, sustaining its growth amid a fiercely competitive and rapidly evolving market. Through this integrated approach, the company solidifies its position as a crucial conduit in the delivery of healthcare solutions across China.

Intrinsic Value
81 CNY
Undervaluation 68%
Intrinsic Value
Price
C

See Also

What is China National Accord Medicines Corp Ltd's Revenue?
Revenue
75.4B CNY

Based on the financial report for Sep 30, 2024, China National Accord Medicines Corp Ltd's Revenue amounts to 75.4B CNY.

What is China National Accord Medicines Corp Ltd's Revenue growth rate?
Revenue CAGR 10Y
12%

Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for China National Accord Medicines Corp Ltd have been 4% over the past three years , 8% over the past five years , and 12% over the past ten years .

Back to Top